|
CFL1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.383900E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.145790E-02 |
| Normal-vs-Stage2 |
2.037600E-01 |
| Normal-vs-Stage3 |
2.449800E-02 |
| Normal-vs-Stage4 |
1.415410E-04 |
| Stage1-vs-Stage2 |
5.596000E-01 |
| Stage1-vs-Stage3 |
8.118400E-01 |
| Stage1-vs-Stage4 |
8.064400E-03 |
| Stage2-vs-Stage3 |
5.313000E-01 |
| Stage2-vs-Stage4 |
1.313580E-02 |
| Stage3-vs-Stage4 |
1.942160E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.723300E-03 |
| Normal-vs-AfricanAmerican |
5.958400E-03 |
| Normal-vs-Asian |
1.779810E-01 |
| Caucasian-vs-AfricanAmerican |
4.482800E-01 |
| Caucasian-vs-Asian |
7.992400E-01 |
| AfricanAmerican-vs-Asian |
9.629200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.537700E-03 |
| Normal-vs-Female |
6.583700E-03 |
| Male-vs-Female |
8.486600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.033700E-04 |
| Normal-vs-Age(41-60Yrs) |
1.578770E-03 |
| Normal-vs-Age(61-80Yrs) |
3.953700E-02 |
| Normal-vs-Age(81-100Yrs) |
3.677400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.288200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.800380E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.928300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.010200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.091000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.846400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.727900E-02 |
| Normal-vs-Grade 2 |
8.035800E-02 |
| Normal-vs-Grade 3 |
9.283100E-03 |
| Normal-vs-Grade 4 |
9.92389999954213E-07 |
| Grade 1-vs-Grade 2 |
1.800780E-01 |
| Grade 1-vs-Grade 3 |
4.345800E-01 |
| Grade 1-vs-Grade 4 |
2.724200E-01 |
| Grade 2-vs-Grade 3 |
1.551010E-01 |
| Grade 2-vs-Grade 4 |
2.41219999999043E-05 |
| Grade 3-vs-Grade 4 |
4.374800E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.285200E-01 |
| Normal-vs-ccB subtype |
8.14150000000291E-05 |
| ccA subtype-vs-ccB subtype |
2.50679999980186E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.433880E-02 |
| Normal-vs-N1 |
1.833410E-04 |
| N0-vs-N1 |
1.438190E-02 |
|
|
